Statins vs placebo
- Statins versus placebo for people with chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes onlyno estimate extracted8 studies · 8 participantsGRADE not reported
Statins showed no clear difference in adverse events leading to discontinuation of therapy compared with placebo (high certainty).
The review found no eligible studies for this question.
It is very uncertain whether statins with cholesterol supplementation changes statin‐related adverse events compared with cholesterol supplementation only (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether the intervention changes adverse events (very low certainty).
The intervention showed no clear difference in adverse events ‐ at one year (moderate certainty).
Statin showed no clear difference in adverse events ‐ Muscle pain compared with placebo (moderate certainty).
The review found no eligible studies for this question.